FDA panel backs imaging agent for appendicitis
This article was originally published in Clinica
Executive Summary
An advisory panel to the US FDA has unanimously recommended that the agency approves Palatin Technologies' LeuTech imaging agent for diagnosing equivocal appendicitis.